Products for Research Use Only
RegisterLogin

α-Casein (90-95) (TFA)

CAT: 0804-HY-P1793A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P1793A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
α-Casein (90-95) TFA is a partial agonist of opioid receptors and a copper ion ligand, with opioid activity. α-Casein (90-95) TFA inhibits the secretion of β-hexosaminidase by rat peritoneal mast cells (PMC) with IC50= 0.1 μM. α-Casein (90-95) TFA inhibits the proliferation of prostate cancer cells LNCaP, DU145, and PC3 with IC50 of 0.94 nM, 137 nM, and 6.92 nM, respectively. α-Casein (90-95) TFA activates Gi-like proteins through a membrane-assisted, receptor-independent pathway, or reversibly binds to opioid receptors, inducing intracellular calcium release and conformational changes, and exerts the activity of promoting mast cell secretion and inhibiting tumor cell proliferation. α-Casein (90-95) TFA can be used in the study of the mechanisms of allergic diseases and prostate cancer[1][2][3].
UNSPSC
12352209
Target
Biochemical Assay Reagents; Opioid Receptor
Type
Peptides
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/α-casein-90-95-tfa.html
Purity
99.58
Solubility
H2O : ≥ 100 mg/mL
Smiles
OC(C(F)(F)F)=O.O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N
Molecular Formula
C40H58F3N9O11
Molecular Weight
897.94
References & Citations
[1]Chruścińska E, et al. Binding ability of Cu2+ ions by opiate-like fragments of bovine casein. J Inorg Biochem. 1997 Apr;66 (1) :19-22.|[2]Stępnik M, et al. The influence of bovine casein-derived exorphins on mast cells in rodents[J]. Revue française d'allergologie et d'immunologie clinique, 2002, 42 (5) : 447-453.|[3]Kampa M, et al. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol. 1997 Sep 24;335 (2-3) :255-65.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P1793-01α-Casein (90-95)
HY-P10187α-Casein (90-96)
HY-P4704A-01α-Synuclein (61-95) (human) (TFA)
HY-125865-01Casein
HY-P5380ATNO211 (TFA)
HY-P4668A-01Valylleucine (TFA)
HY-P11296A-01LLVK (TFA)
HY-P10927A-01BRP (TFA)
HY-P10333A-01LIH383 (TFA)
HY-P3970D-01KQFK (TFA)

Alternative Products

CatalogName
A9069-1α-Casein (90-95) TFA
TP1695-01α-Casein (90-95)
H-2000.0025a-Casein (90-95)
M30394Α-Casein 90-95
C2085-01Casein, alpha (90-95)
MBS8246050-01Alpha-Casein (90-95)
5-00380alfa-Casein (90-95)
GTR18891286Alpha Casein (90-95) peptide
sc-500900Alpha-Casein (Fragment 90-95)
H-2005.0005a-Casein (90-96)

Popular Products